Simmons Law Firm Investigates FDA Concern about Popular Birth Control’s Increased Risk of Blood Clots in Women

Share Article

Simmons Law Firm Continues to Investigate Rising Safety Concerns Surrounding Yaz and Yasmin, as Provided by Recent FDA Update

News Image
When the FDA meets, it will be to determine if these dangerous drugs should be allowed to stay on the market,

The Simmons Law Firm is investigating reports of the increased risk of blood clots in women taking the popular birth control drugs Yaz, Yasmin and other contraceptives that contain the active ingredient drospirenone. As cited in a recent FDA update, the Food and Drug Administration remains concerned about the possibility of serious to fatal blood clots occurring in women taking contraceptives that contain the active ingredient drospirenone.

An FDA panel has been scheduled on Dec. 8 to review preliminary findings from an FDA study involving 800,000 women, which suggested that women who used birth control containing drospirenone were 1.5 times more likely to experience serious and sometimes fatal blood clots than users of other hormonal contraceptives. Drospirenone is a type of female sex hormone called a progestin which is used in pills including Yaz and Yasmin.

Simmons Browder Gianaris Angelides & Barnerd LLC has been investigating thousands of claims that Yaz and Yasmin have caused serious side effects including fatal blood clots.

“When the FDA meets, it will be to determine if these dangerous drugs should be allowed to stay on the market,” said Simmons Partner Trent Miracle, who is one of the attorneys leading the national litigation against Bayer, the company that manufactures Yaz and Yasmin. “Many women have been led to believe that the risks of Yaz and Yasmin were similar to other hormonal contraceptives, when that is not the case. Other alternatives are available which are just as effective and much safer.”

The FDA panel will review six conflicting studies regarding drospirenone’s increased risk of causing blood clots to form inside a vein, a condition called deep vein thrombosis. The clots most often occur in the leg or thigh. They can break loose and travel through the blood to other areas of the body like the lungs and trigger a pulmonary embolism. Severe symptoms of a PE include low blood oxygen, collapse, and sudden death.

“This is a very serious health concern for women who have been negatively impacted by these drugs,” Miracle said. “These women and their families are asking a lot of questions, and the Simmons Firm is hoping to help them find the answers they deserve.”

The Yaz Attorneys at the Simmons Law Firm are currently investigating claims against Yaz, Yasmin and other drospirenone drugs.

About Simmons Browder Gianaris Angelides & Barnerd LLC

The Simmons Firm is a leading law firm in pharmaceutical litigation. The Simmons Firm has experience in litigating complex medical matters and has taken a leadership role in standing up for individuals who have been injured by dangerous or defective drugs. The firm has represented thousands of pharmaceutical lawsuit clients and recovered more than $230 million in verdicts and settlements in cases involving Oxycontin, Vioxx and more. Learn more at http://www.simmonspharmalaw.com.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Mark Motley
Visit website